Literature DB >> 8630491

A novel X-linked gene, G4.5. is responsible for Barth syndrome.

S Bione1, P D'Adamo, E Maestrini, A K Gedeon, P A Bolhuis, D Toniolo.   

Abstract

Barth syndrome is a severe inherited disorder, often fatal in childhood, characterized by cardiac and skeletal myopathy, short stature and neutropenia. The disease has been mapped to a very gene-rich region in distal portion of Xq28. We now report the identification of unique mutations in one of the genes in this region, termed G4.5, expressed at high level in cardiac and skeletal muscle. Different mRNAs can be produced by alternative splicing of the primary G4.5 transcript, encoding novel proteins that differ at the N terminus and in the central region. The mutations introduce stop codons in the open reading frame interrupting translation of most of the putative proteins (which we term 'tafazzins'). Our results suggest that G4.5 is the genetic locus responsible for the Barth syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630491     DOI: 10.1038/ng0496-385

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  227 in total

1.  The oxen gene of Drosophila encodes a homolog of subunit 9 of yeast ubiquinol-cytochrome c oxidoreductase complex: evidence for modulation of gene expression in response to mitochondrial activity.

Authors:  M V Frolov; E V Benevolenskaya; J A Birchler
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

2.  Normal pituitary function in a Japanese patient with Barth syndrome.

Authors:  Yuriko Katsushima; Ikuma Fujiwara; Osamu Sakamoto; Toshihiro Ohura; Shigeaki Miyabayashi; Akira Ohnuma; Seiji Yamaguchi; Kazuie Iinuma
Journal:  Eur J Pediatr       Date:  2002-01       Impact factor: 3.183

Review 3.  Many roads lead to a broken heart: the genetics of dilated cardiomyopathy.

Authors:  J Schönberger; C E Seidman
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

4.  Barth syndrome diagnosed in the subclinical stage of heart failure based on the presence of lipid storage myopathy and isolated noncompaction of the ventricular myocardium.

Authors:  Atsuhito Takeda; Akira Sudo; Masafumi Yamada; Hirokuni Yamazawa; Gaku Izumi; Ichizo Nishino; Tadashi Ariga
Journal:  Eur J Pediatr       Date:  2011-09-20       Impact factor: 3.183

Review 5.  Evolving molecular diagnostics for familial cardiomyopathies: at the heart of it all.

Authors:  Thomas E Callis; Brian C Jensen; Karen E Weck; Monte S Willis
Journal:  Expert Rev Mol Diagn       Date:  2010-04       Impact factor: 5.225

Review 6.  The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years.

Authors:  James D Wilkinson; David C Landy; Steven D Colan; Jeffrey A Towbin; Lynn A Sleeper; E John Orav; Gerald F Cox; Charles E Canter; Daphne T Hsu; Steven A Webber; Steven E Lipshultz
Journal:  Heart Fail Clin       Date:  2010-10       Impact factor: 3.179

7.  Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle.

Authors:  Diti Ronvelia; Jaclyn Greenwood; Julia Platt; Simin Hakim; Michael V Zaragoza
Journal:  Mol Genet Metab       Date:  2012-09-18       Impact factor: 4.797

8.  Unremodeled and remodeled cardiolipin are functionally indistinguishable in yeast.

Authors:  Matthew G Baile; Murugappan Sathappa; Ya-Wen Lu; Erin Pryce; Kevin Whited; J Michael McCaffery; Xianlin Han; Nathan N Alder; Steven M Claypool
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

9.  Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.

Authors:  Tomohiro Kimura; Atsuko K Kimura; Mindong Ren; Bob Berno; Yang Xu; Michael Schlame; Richard M Epand
Journal:  Biochemistry       Date:  2018-03-30       Impact factor: 3.162

Review 10.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil?

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.